Trial Profile
Regulatory Post Marketing Surveillance Study on YAZ.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2015
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Acne; Pregnancy; Premenstrual dysphoric disorder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 22 May 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 22 May 2012 Actual patient number (770) added as reported by ClinicalTrials.gov.
- 22 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.